Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 36 Neoplasms, Plasma Cell 12 Prostatic Neoplasms 4 Neoplasms 3 Lymphoma, Mantle-Cell 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1

Interventions

fludarabine phosphate 36 Whole-Body Irradiation 30 Cyclophosphamide 30 Mycophenolic Acid 28 Azacitidine 27 Tacrolimus 25 Peripheral Blood Stem Cell Transplantation 24 Busulfan 22 Methotrexate 15 Cyclosporine 15 Antilymphocyte Serum 14 Decitabine 11 Cytarabine 11 Melphalan 10 fludarabine 9 Radiotherapy 8 Filgrastim 8 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Cord Blood Stem Cell Transplantation 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Cyclosporins 6 Clofarabine 6 venetoclax 5 merphos 5 Sorafenib 4 Lenalidomide 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡